Journals
Publish with us
Publishing partnerships
About us
Blog
Surgery Research and Practice
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Surgery Research and Practice
/
2020
/
Article
/
Tab 3
/
Research Article
A Comparison of Treatments and Outcomes for Medullary versus Nonmedullary Colon Cancer: A Single Institutional Experience Showing a Worse Prognosis for Stage 3 Disease
Table 3
Overall survival and follow-up of those surgically resected MCC vs. NMC.
MCC
NMC
MCC vs. NMC
MCC vs. PD/UD NMC
Total
Total
PD/UD
value
value
Median overall survival, months (95% CI)
Stage 1
Not reached
Not reached
Not reached
0.795
n/a
Stage 2
112.3 (14.1, NA)
97.8 (82.8, NA)
Not reached
0.301
0.283
Stage 3
15.3 (0.9, NA)
61.9 (54.1, 77.1)
47.2 (31.1, NA)
<0.0001
0.001
Stage 4
20.2 (NA, NA)
20.6 (16.3, 25.2)
10.4 (6.8, 16.5)
0.689
0.805
Median follow-up, months (95% CI)
All patients
31.6 (17.7, NA)
57.7 (53.1, 61.2)
48.5 (45.9, 60.0)
0.015
0.031
Stage denotes pathologic stage. MCC, medullary colon cancer; NMC, nonmedullary colon cancer; PD, poorly differentiated; UD, undifferentiated.